Page 1 of Clinical Trials for Ascenta Therapeutics [SPONSOR-COLLABORATORS], 14 Total Matches
- 1CompletedLast Updated: August 20, 2010Condition(s): Hormone Refractory Prostate Cancer
- 2CompletedLast Updated: June 24, 2011Condition(s): Follicular Lymphoma; Diffuse Large Cell Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia
- 3RecruitingLast Updated: January 11, 2012Condition(s): Cancer; Solid Tumors; Lymphoma; Malignancy
- 4CompletedLast Updated: August 24, 2010Condition(s): Non-small Cell Lung Cancer
- 5CompletedLast Updated: November 8, 2010Condition(s): Hormone Refractory Prostate Cancer
- 6CompletedLast Updated: August 12, 2010Condition(s): Chronic Lymphocytic Leukemia
- 7CompletedLast Updated: August 24, 2010Condition(s): Follicular Lymphoma
- 8CompletedLast Updated: June 27, 2011Condition(s): Prostate Cancer
- 9CompletedLast Updated: August 20, 2010Condition(s): Small Cell Lung Cancer
- 10Active, not recruitingLast Updated: February 3, 2010Condition(s): Locally Advanced Esophageal or GE Junction Cancer
- 11RecruitingLast Updated: January 11, 2012Condition(s): Acute Myelogenous Leukemia (AML)
- 12TerminatedLast Updated: November 22, 2011Condition(s): Lung Cancer
- 13TerminatedLast Updated: September 21, 2011Condition(s): Lymphocytic Leukemia; Chronic B-Cell Leukemia
- 14WithdrawnLast Updated: January 25, 2011Condition(s): Carcinoma, Non Small Cell Lung
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Ascenta+Therapeutics
